Nektar Therapeutics (ITH0.STU) Q1 2026 Earnings

12MarConfirmed
Q1 2026
-2.15
-1.95
-1.75
-1.55

Details

Expected EPS
-2.14790120095
Actual EPS
-1.545307
Surprise EPS
0.6
Surprise Percent
+28.06%

Description

Nektar Therapeutics (ITH0.STU) has reported earnings of -1.545307 per share for Q1 2026.

0 Comments

Share your thoughts